Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAPINAROF vs TARLATAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TAPINAROF vs TARLATAMAB: Safety Overview

Metric TAPINAROF TARLATAMAB
Total FAERS Reports 1,387 145
Deaths Reported 2 49
Death Rate 0.1% 33.8%
Hospitalizations 25 52
Average Patient Age 53.0 yrs 62.7 yrs
% Female Patients 51.7% 34.0%
FDA Approval Date May 23, 2022 N/A
Manufacturer Organon LLC N/A
Route TOPICAL N/A
Marketing Status Prescription N/A